Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw

Journal of Neurochemistry

Volumn 113, Issue 3, 2010, Pages 784-795

  Ajmo, Joanne M ^a   Bailey, Lauren A ^b   Howell, Matthew D ^b   Cortez, Lisa K ^b   Pennypacker, Keith R ^a   Mehta, Hina N ^b   Morgan, Dave ^a,c   Gordon, Marcia N ^a,c   Gottschall, Paul E ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

ADAMTS; Alzheimer's disease; Amyloid protein; Chondroitin sulfate; MMP; Proteoglycan

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BREVICAN; CHONDROITIN SULFATE; PROTEOGLYCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DISEASE COURSE; GENE MUTATION; GENE OVEREXPRESSION; HIPPOCAMPUS; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEFECT; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEOGLYCAN SYNTHESIS; SENILE PLAQUE; SYNAPSE; TELENCEPHALON; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CELL LINE; CHONDROITIN SULFATES; CULTURE MEDIA; EXTRACELLULAR SPACE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOCHONDROITIN SULFATES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENILE PLAQUES;

MUS; MUS MUSCULUS;

EID: 77950679263     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06647.x     Document Type: Article

References (63)

1. Ajmo J. M., Eakin A. K., Hamel M. G. Gottschall P. E. (2008) Discordant localization of WFA reactivity and brevican/ADAMTS-derived fragment in rodent brain. BMC Neurosci. 9, 14.
2. Aldridge G. M., Podrebarac D. M., Greenough W. T. Weiler I. J. (2008) The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. J. Neurosci. Methods 172, 250 254.
3. Arendt T. (2009) Synaptic degeneration in Alzheimer's disease. Acta Neuropathol. 118, 167 179.
4. Asahina M., Yoshiyama Y. Hattori T. (2001) Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain. Clin. Neuropathol. 20, 60 63.
5. Backstrom J. R., Lim G. P., Cullen M. J. Tokes Z. A. (1996) Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). J. Neurosci. 16, 7910 7919.
6. Bandtlow C. E. Zimmermann D. R. (2000) Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol. Rev. 80, 1267 1290.
7. Castellani R. J., Lee H. G., Zhu X., Perry G. Smith M. A. (2008) Alzheimer disease pathology as a host response. J. Neuropathol. Exp. Neurol. 67, 523 531.
8. Cotman S. L., Halfter W. Cole G. J. (2000) Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain. Mol. Cell. Neurosci. 15, 183 198.
9. Deb S., Wenjun Zhang J. Gottschall P. E. (2003) Beta-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes. Brain Res. 970, 205 213.
10. Dong H., Martin M. V., Chambers S. Csernansky J. G. (2007) Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice. J. Comp. Neurol. 500, 311 321.
11. Drouet B., Pincon-Raymond M., Chambaz J. Pillot T. (1999) Laminin 1 attenuates beta-amyloid peptide Abeta(1-40) neurotoxicity of cultured fetal rat cortical neurons. J. Neurochem. 73, 742 749.
12. Flannery C. R. (2006) MMPs and ADAMTSs: functional studies. Front Biosci. 11, 544 569.
13. Flannery C. R., Zeng W., Corcoran C. et al. (2002) Autocatalytic cleavage of ADAMTS-4 (Aggrecanase-1) reveals multiple glycosaminoglycan-binding sites. J. Biol. Chem. 277, 42775 42780.
14. Flood C., Gustafsson M., Richardson P. E., Harvey S. C., Segrest J. P. Boren J. (2002) Identification of the proteoglycan binding site in apolipoprotein B48. J. Biol. Chem. 277, 32228 32233.
15. Frischknecht R., Heine M., Perrais D., Seidenbecher C. I., Choquet D. Gundelfinger E. D. (2009) Brain extracellular matrix affects AMPA receptor lateral mobility and short-term synaptic plasticity. Nat. Neurosci. 12, 897 904.
16. Glenner G. G. Wong C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885 890.
17. Gordon M. N., King D. L., Diamond D. M. et al. (2001) Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice. Neurobiol. Aging 22, 377 385.
18. Gottschall P. E. (1996) beta-Amyloid induction of gelatinase B secretion in cultured microglia: inhibition by dexamethasone and indomethacin. Neuroreport 7, 3077 3080.
19. Gottschall P. E., Sandy J. D. Zimmermann D. R. (2005) Substrates for metalloendopeptidases in the central nervous system, in Matrix Metalloproteinases in the Central Nervous System (Conant K. Gottschall P. E., eds), pp. 87 118. Imperial College Press
20. Haass C. Selkoe D. J. (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 101 112.
21. Hagihara K., Miura R., Kosaki R., Berglund E., Ranscht B. Yamaguchi Y. (1999) Immunohistochemical evidence for the brevican-tenascin-R interaction: colocalization in perineuronal nets suggests a physiological role for the interaction in the adult rat brain. J. Comp. Neurol. 410, 256 264.
22. Hamel M. G., Ajmo J. M., Leonardo C. C., Zuo F., Sandy J. D. Gottschall P. E. (2008) Multimodal signaling by the ADAMTSs (a disintegrin and metalloproteinase with thrombospondin motifs) promotes neurite extension. Exp. Neurol. 210, 428 440.
23. Hockfield S., Kalb R. G., Zaremba S. Fryer H. (1990) Expression of neural proteoglycans correlates with the acquisition of mature neuronal properties in the mammalian brain. Cold Spring Harb. Symp. Quant. Biol. 55, 505 514.
24. Hsiao K. K., Borchelt D. R., Olson K. et al. (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15, 1203 1218.
25. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F. Cole G. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99 102.
26. John N., Krugel H., Frischknecht R., Smalla K. H., Schultz C., Kreutz M. R., Gundelfinger E. D. Seidenbecher C. I. (2006) Brevican-containing perineuronal nets of extracellular matrix in dissociated hippocampal primary cultures. Mol. Cell. Neurosci. 31, 774 784.
27. Kowalska M. A. Badellino K. (1994) beta-Amyloid protein induces platelet aggregation and supports platelet adhesion. Biochem. Biophys. Res. Commun. 205, 1829 1835.
28. Lacor P. N., Buniel M. C., Chang L. et al. (2004) Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J. Neurosci. 24, 10191 10200.
29. Leake A., Morris C. M. Whateley J. (2000) Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease. Neurosci. Lett. 291, 201 203.
30. Lee J. M., Yin K. J., Hsin I., Chen S., Fryer J. D., Holtzman D. M., Hsu C. Y. Xu J. (2003) Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy. Ann. Neurol. 54, 379 382.
31. Lee J. M., Yin K., Hsin I., Chen S., Fryer J. D., Holtzman D. M., Hsu C. Y. Xu J. (2005) Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy- related hemorrhage. J. Neurol. Sci. 229-230, 249-254.
32. Lorenzl S., Albers D. S., Relkin N., Ngyuen T., Hilgenberg S. L., Chirichigno J., Cudkowicz M. E. Beal M. F. (2003) Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochem. Int. 43, 191 196.
33. Malemud C. J. (2006) Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci. 11, 1696 1701.
34. Matthews R. T., Gary S. C., Zerillo C., Pratta M., Solomon K., Arner E. C. Hockfield S. (2000) Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member. J. Biol. Chem. 275, 22695 22703.
35. Mayer J., Hamel M. G. Gottschall P. E. (2005) Evidence for proteolytic cleavage of brevican by the ADAMTSs in the dentate gyrus after excitotoxic lesion of the mouse entorhinal cortex. BMC Neurosci. 6, 52.
36. McGeer P. L., Akiyama H., Itagaki S. McGeer E. G. (1989) Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16, 516 527.
37. Morgan D., Diamond D. M., Gottschall P. E. et al. (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408, 982 985.
38. Mori R., Wang Q., Danenberg K. D., Pinski J. K. Danenberg P. V. (2008) Both beta-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer. Prostate 68, 1555 1560.
39. Mucke L., Masliah E., Yu G. Q. et al. (2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050 4058.
40. Nairn A. V., Kinoshita-Toyoda A., Toyoda H. et al. (2007) Glycomics of proteoglycan biosynthesis in murine embryonic stem cell differentiation. J. Proteome Res. 6, 4374 4387.
41. Nakamura H., Fujii Y., Inoki I., Sugimoto K., Tanzawa K., Matsuki H., Miura R., Yamaguchi Y. Okada Y. (2000) Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. J. Biol. Chem. 275, 38885 38890.
42. Okada Y. (2000) Tumor cell-matrix interaction: pericellular matrix degradation and metastasis. Verh. Dtsch. Ges. Pathol. 84, 33 42.
43. Palop J. J., Chin J. Mucke L. (2006) A network dysfunction perspective on neurodegenerative diseases. Nature 443, 768 773.
44. Pizzi M. A. Crowe M. J. (2006) Matrix metalloproteinases and proteoglycans in axonal regeneration. Exp. Neurol. 204, 496 511.
45. Reeves T. M., Prins M. L., Zhu J., Povlishock J. T. Phillips L. L. (2003) Matrix metalloproteinase inhibition alters functional and structural correlates of deafferentation-induced sprouting in the dentate gyrus. J. Neurosci. 23, 10182 10189.
46. Sastre M., Klockgether T. Heneka M. T. (2006) Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. Int. J. Dev. Neurosci. 24, 167 176.
47. Satoh K., Suzuki N. Yokota H. (2000) ADAMTS-4 (a disintegrin and metalloproteinase with thrombospondin motifs) is transcriptionally induced in beta-amyloid treated rat astrocytes. Neurosci. Lett. 289, 177 180.
48. Selkoe D. J. (1991) Alzheimer's disease. In the beginning. Nature 354, 432 433.
49. Selkoe D. J. (2002) Alzheimer's disease is a synaptic failure. Science 298, 789 791.
50. Tannock L. R. King V. L. (2008) Proteoglycan mediated lipoprotein retention: a mechanism of diabetic atherosclerosis. Rev. Endocr. Metab. Disord. 9, 289 300.
51. Terai K., Iwai A., Kawabata S., Tasaki Y., Watanabe T., Miyata K. Yamaguchi T. (2001) beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. Neuroscience 104, 299 310.
52. Thon N., Haas C. A., Rauch U., Merten T., Fassler R., Frotscher M. Deller T. (2000) The chondroitin sulphate proteoglycan brevican is upregulated by astrocytes after entorhinal cortex lesions in adult rats. Eur. J. Neurosci. 12, 2547 2558.
53. Tortorella M. D., Pratta M., Liu R. Q., Austin J., Ross O. H., Abbaszade I., Burn T. Arner E. (2000) Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4). J. Biol. Chem. 275, 18566 18573.
54. Viapiano M. S., Matthews R. T. Hockfield S. (2003) A novel membrane-associated glycovariant of BEHAB/brevican is up-regulated during rat brain development and in a rat model of invasive glioma. J. Biol. Chem. 278, 33239 33247.
55. Viapiano M. S., Bi W. L., Piepmeier J., Hockfield S. Matthews R. T. (2005) Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas. Cancer Res. 65, 6726 6733.
56. Watanabe N., Araki W., Chui D. H., Makifuchi T., Ihara Y. Tabira T. (2004) Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease. FASEB J. 18, 1013 1015.
57. Wilcock D. M., Gordon M. N., Ugen K. E. et al. (2001) Number of Abeta inoculations in APP+PS1 transgenic mice influences antibody titers, microglial activation, and congophilic plaque levels. DNA Cell Biol. 20, 731 736.
58. Yamada H., Watanabe K., Shimonaka M. Yamaguchi Y. (1994) Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. J. Biol. Chem. 269, 10119 10126.
59. Yamaguchi Y. (2000) Lecticans: organizers of the brain extracellular matrix. Cell. Mol. Life Sci. 57, 276 289.
60. Yan P., Hu X., Song H. et al. (2006) Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ. J. Biol. Chem. 281, 24566 24574.
61. Yin K. J., Cirrito J. R., Yan P. et al. (2006) Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J. Neurosci. 26, 10939 10948.
62. Yoshiyama Y., Asahina M. Hattori T. (2000) Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain. Acta Neuropathol. 99, 91 95.
63. Yuan W., Matthews R. T., Sandy J. D. Gottschall P. E. (2002) Association between protease-specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainate-treated rats. Neuroscience 114, 1091 1101.